Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

The clinical significance of an autoimmune response against glutamic acid decarboxylase

Nature Medicine volume 2, pages 148–153 (1996)Cite this article

Glutamic acid decarboxylase is attracting much interest because of its putative involvement in two clinical disorders: stiff-man syndrome and insulin-dependent diabetes. Here we discuss the clinical significance of an autoimmune response against CAD and consider how such information may help identify the disease mechanisms of these disorders.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Erlander, M.G. & Tobin, A.J. The structural and functional heterogeneity of glutamic acid decarboxylase: A review. Neurochem. Res. 16, 215–226 (1991).

    Article  CAS  Google Scholar 

  2. Erdo, S. & Wolff, J. Gamma-aminobutyric acid outside the mammalian brain. J. Neurochem. 54, 363–372 (1990).

    Article  CAS  Google Scholar 

  3. Kaufman, D.L., Houset, C.R. & Tobin, A.J. Two forms of the GABA synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 56, 720–723 (1991).

    Article  CAS  Google Scholar 

  4. Moersch, P.P. & Woltman, H.W. Progressive fluctuating muscular rigidity and spasm (“stiff-man” syndrome): Report of a case and some observations in 13 other cases. Mayo Clin. Proc. 31, 421–427 (1957).

    Google Scholar 

  5. Layzer, R.B. Stiff-man syndrome—an autoimmune disease? N. Engl. J. Med. 318, 1060–1062 (1988).

    Article  CAS  Google Scholar 

  6. Solimena, M. et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy and type-1 diabetes. N. Engl. J. Med. 318, 1012–1020 (1988).

    Article  CAS  Google Scholar 

  7. Solimena, M., Folli, F., Aparisi, R., Pozza, G. & De Camilli, P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N. Engl. J. Med. 322, 1555–1560 (1990).

    Article  CAS  Google Scholar 

  8. Baekkeskov, S. et al. The 64kD autoantigen in insulin-dependent diabetes is the GABA synthesizing enzyme glutamic acid decarboxylase. Nature 347, 151–156 (1990).

    Article  CAS  Google Scholar 

  9. Aanstoot, H. et al. Stiff-man syndrome and insulin dependent diabetes mellitus similarities in autoimmune reactions. in Motor Unit Hyperactivity States (ed.Layzer,R.B.) 53–67 (Raven, New York, 1993).

    Google Scholar 

  10. Atkinson, M.A. & Maclaren, N.K. The pathogenesis of insulin dependent diabetes. N. Engl. J. Med. 331, 1428–1436 (1994).

    Article  CAS  Google Scholar 

  11. Baekkeskov, S. et al. Autoantibodies in newly diagnosed diabetic children with immunoprecipitate human pancreatic islet cell proteins. Nature 298, 167–169 (1982).

    Article  CAS  Google Scholar 

  12. Atkinson, M.A., Maclaren, N.K., Scharp, D.W., Lacy, P.E. & Riley, W.J. 64,000 Mr autoantibodies are predictive of insulin dependent diabetes. Lancet 335, 1357–1360 (1990).

    Article  CAS  Google Scholar 

  13. Richter, W., Shi Y. & Baekkeskov, S. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc. Natl. Acad. Sci. USA 90, 2832–2836 (1993).

    Article  CAS  Google Scholar 

  14. Gianani, R.A. et al. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies of patients with type 1 diabetes. Diabetes 41, 347–353 (1992).

    Article  CAS  Google Scholar 

  15. Atkinson, M.A., Kaufman, D.L., Newman, D., Tobin, A.J. & Maclaren, N.K. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J. Clin. Invest. 91, 350–356 (1993).

    Article  CAS  Google Scholar 

  16. Tuomilehto, J. et al. Antibodies to glutamic acid decarboxylaseaspredictorsofinsulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343, 1383–1385 (1994).

    Article  CAS  Google Scholar 

  17. Atkinson, M.A. et al. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339, 458–459 (1992).

    Article  CAS  Google Scholar 

  18. Harrison, L.C. et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependentdiabetes. Lancet 341, 1365–1369 (1993).

    Article  CAS  Google Scholar 

  19. Lohmann, T. et al. Immunodominant epitopes of glutamic acid decarboxylase 65and 67 in insulin-dependent diabetes mellitus. Lancet 343, 1606–1608 (1994).

    Article  Google Scholar 

  20. Atkinson, M.A. et al. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J. Clin. Invest. 94, 2125–2129 (1994).

    Article  CAS  Google Scholar 

  21. Kaufman, D.L. et al. Spontaneous loss of T cell self tolerance to glutamate decarboxylase is a key event in the pathogenesis of murine insulin-dependent diabetes. Nature 366, 69–71 (1993).

    Article  CAS  Google Scholar 

  22. Jones, D.B. & Armstrong, N.W. Coxsackie virus and diabetes revisited. Nature Med. 1, 284 (1995).

    Article  CAS  Google Scholar 

  23. Tian, J., Lehmann, P.V. & Kaufman, D.L. T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp. Med. 180, 1979–1984 (1994).

    Article  CAS  Google Scholar 

  24. Kaufman, D. et al. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent mellitus. J. Clin. Invest. 89, 283–292 (1992).

    Article  CAS  Google Scholar 

  25. Solimena, M. & DeCamilli, P. Autoimmunity to glutamate decarboxylase (GAD) in stiff man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci. 14, 452–457 (1991).

    Article  CAS  Google Scholar 

  26. Kim, J. et al. Higher autoantibody levels and recognition of a linear NH-2 terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin dependentdiabetes mellitus. J. Exp. Med. 180, 595–606 (1994).

    Article  CAS  Google Scholar 

  27. Butler, M.H., Solimena, M., Dirkx, R., Mayday, A. & DeCamilli, P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies is stiff-man syndrome. J. Exp. Med. 178, 2097–2106 (1993).

    Article  CAS  Google Scholar 

  28. Ujihara, N. et al. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type 1 diabetes. Diabetes 43, 968–975 (1994).

    Article  CAS  Google Scholar 

  29. Seder, R.A. & Paul, W.E. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12, 635–673 (1994).

    Article  CAS  Google Scholar 

  30. Tish, R. et al. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366, 72–75 (1993).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida, 32610, USA

    T.M. Ellis & M.A. Atkinson

Authors
  1. T.M. Ellis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M.A. Atkinson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ellis, T., Atkinson, M. The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nat Med 2, 148–153 (1996). https://doi.org/10.1038/nm0296-148

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0296-148

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing